Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara Mirzadegan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|May 27, 2006
Recent progress in the design of small molecule inhibitors of HIV RNase HKlaus Klumpp, Tara Mirzadegan
Journal of Computer-Aided Molecular Design|December 21, 2016
Computational chemistry at JanssenHerman van Vlijmen, Renee L Desjarlais, Tara Mirzadegan
Biochemistry|March 12, 2003
Sequence analyses of G-protein-coupled receptors: similarities to rhodopsinTara Mirzadegan, Gil Benkö, Sławomir Filipek, et al.
Biochemical and Biophysical Research Communications|November 23, 2006
Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)Julie Q Hang, Yu Li, Yanli Yang, et al.
Molecular Pharmacology|December 22, 2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonistsRama Kondru, Jun Zhang, Changhua Ji, et al.
The Journal of Biological Chemistry|April 30, 2016
A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP InhibitorsJonathan M Blevitt, Michael D Hack, Krystal Herman, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2010
Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonismRalph N Harris, Russel S Stabler, David B Repke, et al.
Journal of Medicinal Chemistry|November 30, 2004
Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agentsTodd R Elworthy, Emma R Brill, San-San Chiou, et al.
The Journal of Biological Chemistry|June 14, 2013
Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.
Journal of Computer-Aided Molecular Design|January 12, 2019
D3R Grand Challenge 3: blind prediction of protein-ligand poses and affinity rankingsZied Gaieb, Conor D Parks, Michael Chiu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|May 27, 2006
Recent progress in the design of small molecule inhibitors of HIV RNase HKlaus Klumpp, Tara Mirzadegan
Journal of Computer-Aided Molecular Design|December 21, 2016
Computational chemistry at JanssenHerman van Vlijmen, Renee L Desjarlais, Tara Mirzadegan
Biochemistry|March 12, 2003
Sequence analyses of G-protein-coupled receptors: similarities to rhodopsinTara Mirzadegan, Gil Benkö, Sławomir Filipek, et al.
Biochemical and Biophysical Research Communications|November 23, 2006
Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)Julie Q Hang, Yu Li, Yanli Yang, et al.
Molecular Pharmacology|December 22, 2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonistsRama Kondru, Jun Zhang, Changhua Ji, et al.
The Journal of Biological Chemistry|April 30, 2016
A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP InhibitorsJonathan M Blevitt, Michael D Hack, Krystal Herman, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2010
Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonismRalph N Harris, Russel S Stabler, David B Repke, et al.
Journal of Medicinal Chemistry|November 30, 2004
Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agentsTodd R Elworthy, Emma R Brill, San-San Chiou, et al.
The Journal of Biological Chemistry|June 14, 2013
Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.
Journal of Computer-Aided Molecular Design|January 12, 2019
D3R Grand Challenge 3: blind prediction of protein-ligand poses and affinity rankingsZied Gaieb, Conor D Parks, Michael Chiu, et al.
Pageof 2